chevron_leftBack
As of 13 July 2026, Herborium Group, Inc. has a market cap of $1.14M USD, ranking #48553 globally and #6243 in the United States.
It ranks #4308 in the Healthcare sector, and #348 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$1.14MUSD
Revenue (TTM)
$259.1KUSD
EBITDA (TTM)
-$250.2KUSD
Net Income (TTM)
$68.2KUSD
EBITDA Margin
-97%
Profit Margin
26%
PE Ratio
0.0
PS Ratio
4.4
PB Ratio
-0.9
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Agnes Olszewski
open_in_new
Employees
7
Founded
2000
Website
herborium.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 10K% | 10K% | 10K% | 0% | 0% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
HBRM
Herborium Group Inc
ISIN: US42703A2087
Shares Out.:
Shares Outstanding:
11.419B1
Shares Float:
10.12B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0001 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company offers dermatology products, which include AcnEase, an herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company is headquartered in Sugar Land, Texas.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
3M%
|
-
|
|
LSE: INDV
|
$2.07B
181K%
1.54B GBP
|
-
|
|
NYSE: BRBR
|
$2.06B
180K%
|
12.1
|
|
OTCMKTS: NDOI
|
$1.8B
158K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
154K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
116K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.12B
3M%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.8B
1M%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
977K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
967K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.07B
794K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.65B
757K%
7.57B EUR
|
-
|
chevron_leftBack